Myriad Genetics, Inc. (MYGN) Reports Fourth Quarter and Fiscal Year 2012 Results

8/15/2012 9:29:27 AM

SALT LAKE CITY, Aug. 14, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced results for its fourth quarter and fiscal year ending June 30, 2012. Revenue for the fourth fiscal quarter increased 24 percent over the same period in the prior year to $133.0 million and resulted in fiscal year 2012 revenue of $496.0 million, an increase of 23 percent over fiscal 2011. Fourth fiscal quarter diluted earnings per share were $0.34, an increase of 14 percent over the same period of the prior year. Fiscal 2012 diluted earnings per share equaled $1.30, an increase of 18 percent year-over-year.

Read at GlobeNewswire

Read Article at

Related Companies

News Categories

• GlobeNewswire

• Myriad Genetics, Inc.

• Diagnostics

• Medical Dev. & Diag. - Earnings